Drug Shortage Report for TARO-ROSUVASTATIN
| Report ID | 97750 |
| Drug Identification Number | 02382660 |
| Brand name | TARO-ROSUVASTATIN |
| Common or Proper name | TARO-ROSUVASTATIN |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-24 |
| Estimated end date | 2020-06-19 |
| Actual end date | 2020-06-15 |
| Shortage status | Resolved |
| Updated date | 2020-07-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.